6533b829fe1ef96bd128a5a6
RESEARCH PRODUCT
Clinical features and follow-up in patients with 22q11.2 deletion syndrome
C CancriniP PuliafitoM DigilioA SoresinaS MartinoR RondelliR ConsoliniE RugaF CardinaleA FinocchiMl RomitiB MartireR BacchettaV AlbanoA CarottiF SpecchiaD MontinE CirilloG CocchiA TrizzinoG BossiO MilanesiC AzzariG CorselloC PignataA AiutiM PietrograndeB MarinoA UgazioA PlebaniP RossiP PieraniA GabrielliM DanieliD De MattiaC SistoF DammaccoG RanieriA PessionG RicciP MinelliV LougarisR BadolatoR CattaneoP AiròR MuraF CossuS Del GiaccoP ManconiC ConsarinoA Dello RussoR MinieroE AnastasioS MarinoG RussoR PaganelliD SperlìL CarpinoM AricòE GambineriF LippiC CanessaE MaggiS RomagnaniA MatucciA VultaggioM GattornoE CastagnolaG NigroG PrestaA CivinoF BuziG GambarettoS FasoliC SalpietroR GallizziR DellepianeC PanisiG FabioM CarrabbaM PietrograndeM RoncaroloA BiondiC VallinotoV PoggiG MennaR Di NardoR SottileG MaroneG SpadaroM CarliG BassoC PuttiG SemenzatoC AgostiniP D'angeloG IzziP BertoliniM ZeccaG MarsegliaR MaccarioL FeliciC FavreV VecchiP SacchiniG RinaldiS LivadiottiA SimonettiA StabileM DuseM IacobiniI QuintiM FiorilliV MoscheseF CecereA D'ambrosioG De ZanS StrafellaP TamaroM RabusinA TommasiniP TovoM De CarliS De CarliL NespoliM MarinoniA PorcelliniC LunardiG PatuzzoA BonerD Deganisubject
MalePediatrics22q11.2 deletionDelayed DiagnosisTime FactorsChromosomes Human Pair 22Developmental Disabilitiesdigeorge syndromeSex FactorSeverity of Illness IndexRetrospective StudieDiGeorge syndromeEarly DiagnosiAge FactorProspective StudiesNeonatal hypocalcemiaProspective cohort studyChildmedicine.diagnostic_testDelayed Diagnosi22q11.2 deletion; Primary immune disordersAge Factorsdel 22qMIMAbnormalities Multiple; Adolescent; Adult; Age Factors; Child; Child Preschool; Chromosomes Human Pair 22; Delayed Diagnosis; Developmental Disabilities; DiGeorge Syndrome; Early Diagnosis; Female; Follow-Up Studies; Genetic Testing; Humans; Infant; Infant Newborn; Male; Monitoring Physiologic; Prospective Studies; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Time Factors; Young Adult; Disease ProgressionChild PreschoolCohortDisease ProgressionPrimary immune disordersFemaleAbnormalitiesMultipleAbnormalities Multiple; Adolescent; Adult; Age Factors; Child; Child Preschool; Chromosomes Human Pair 22; Delayed Diagnosis; Developmental Disabilities; DiGeorge Syndrome; Early Diagnosis; Female; Follow-Up Studies; Genetic Testing; Humans; Infant; Infant Newborn; Male; Monitoring Physiologic; Prospective Studies; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Time Factors; Young Adult; Disease Progression; Pediatrics Perinatology and Child HealthHumanAdultmedicine.medical_specialtyTime FactorAdolescentMonitoringDevelopmental DisabilitieItalian Association of Pediatric Haematology and OncologyContext (language use)Risk AssessmentChromosomesFollow-Up StudieYoung AdultSex FactorsSeverity of illnessmedicineDiGeorge SyndromeHumansAbnormalities MultipleGenetic Testing22q11DS; 22q11.2 deletion syndrome; AIEOP; Italian Association of Pediatric Haematology and Oncology; MIM; Mendelian Inheritance in Man22q11DSPreschoolPhysiologicdigeorge syndrome; del 22qGenetic testingMonitoring PhysiologicRetrospective StudiesSettore MED/38 - Pediatria Generale e Specialisticabusiness.industryMendelian Inheritance in ManInfant NewbornInfantRetrospective cohort studymedicine.diseaseNewbornAIEOPProspective StudieEarly Diagnosis22q11.2 deletion syndromePediatrics Perinatology and Child HealthPair 22businessFollow-Up Studiesdescription
Objective To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11.2 deletion syndrome to better define the natural history of the disease. Study design A retrospective and prospective multicenter study was conducted with 228 patients in the context of the Italian Network for Primary Immunodeficiencies. Clinical diagnosis was confirmed by cytogenetic or molecular analysis. Results The cohort consisted of 112 males and 116 females; median age at diagnosis was 4 months (range 0 to 36 years 10 months). The diagnosis was made before 2 years of age in 71% of patients, predominantly related to the presence of heart anomalies and neonatal hypocalcemia. In patients diagnosed after 2 years of age, clinical features such as speech and language impairment, developmental delay, minor cardiac defects, recurrent infections, and facial features were the main elements leading to diagnosis. During follow-up (available for 172 patients), the frequency of autoimmune manifestations ( P = .015) and speech disorders ( P = .002) increased. After a median follow-up of 43 months, the survival probability was 0.92 at 15 years from diagnosis. Conclusions Our data show a delay in the diagnosis of 22q11.2 deletion syndrome with noncardiac symptoms. This study provides guidelines for pediatricians and specialists for early identification of cases that can be confirmed by genetic testing, which would permit the provision of appropriate clinical management.
year | journal | country | edition | language |
---|---|---|---|---|
2014-06-01 |